Stock 301201 CHENGDA PHARMACEUTICALS CO., LTD.
Add to a list
To use this feature you must be a member
Log inSign up

Company ChengDa Pharmaceuticals Co., Ltd.

Equities

301201

CNE100005766

Pharmaceuticals

End-of-day quote Shenzhen S.E.
Other stock markets
 06:00:00 2024-04-29 pm EDT 		5-day change 1st Jan Change
20.21 CNY +2.07% Intraday chart for ChengDa Pharmaceuticals Co., Ltd. +4.99% -20.53%
Apr. 21 ChengDa Pharmaceuticals Co., Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2024 CI
Apr. 01 Tranche Update on ChengDa Pharmaceuticals Co., Ltd.'s Equity Buyback Plan announced on January 9, 2024. CI

Business Summary

Chengda Pharmaceuticals Co Ltd is a China-based company mainly engaged in customized R&D and production of pharmaceutical intermediates. The Company is also engaged in the production and sales of L-carnitine series products and active pharmaceutical ingredients (APIs). The pharmaceutical intermediate products include NP0805/NP0908, NP1205, NP0806, NP1011/1214, NP1709 and others. The L-carnitine series products are used in the fields of food additives, feed additives and raw materials. The APIs products include Buwaxitan, Vidagliptin, Elagoli and others. The Company's products are exported to the United States, Europe, Japan, Canada, the United Kingdom, Italy and other countries and regions.

Number of employees: 504

Sales per Business

CNY in Million2022Weight2023Weight Delta
Self-Selling Products
57.4 %
250 60.7 % 238 57.4 % -4.90%
Active Pharmaceutical Ingredient
42.1 %
160 38.9 % 174 42.1 % +9.03%
Trade
0.3 %
1 0.4 % 1 0.3 % -16.81%
Other Business
0.2 %
0 0.0 % 1 0.2 % +727.26%

Sales per region

CNY in Million2022Weight2023Weight Delta
China
63.9 %
206 50.0 % 265 63.9 % +28.70%
Foreign
36.1 %
206 50.0 % 149 36.1 % -27.35%

Managers

Managers TitleAgeSince
Gang Lu CEO
 Chief Executive Officer 49 99-11-30
Chao Fei DFI
 Director of Finance/CFO 45 05-05-31
Jian Li Ge CHM
 Chairman 71 99-03-24
Hong Lin Huang BRD
 Director/Board Member 62 99-03-24
Xiao Jing Yang PRN
 Corporate Officer/Principal 42 06-01-31

Members of the board

Members of the board TitleAgeSince
Yi Yu BRD
 Director/Board Member 58 19-09-30
Ping Wang BRD
 Director/Board Member 75 19-11-25
Sun Liang Cui BRD
 Director/Board Member 42 19-10-31
Jian Li Ge CHM
 Chairman 71 99-03-24
Hong Lin Huang BRD
 Director/Board Member 62 99-03-24
Gang Lu CEO
 Chief Executive Officer 49 99-11-30
Wei Han Chen CHM
 Chairman 50 99-06-30
Wen Juan Li BRD
 Director/Board Member 43 12-02-29

Share class

VoteQuantityFree-FloatCompany-owned sharesTotal Float
Stock A 1 154,713,824 51,965,961 ( 33.59 %) 2,946,800 ( 1.905 %) 33.59 %

Shareholders

NameEquities%Valuation
Sheng Tai Investment & Management Co. Ltd.
20.71 %
17,391,840 20.71 % 49 M ¥
Cai Yin Zhu
7.239 %
6,080,000 7.239 % 17 M ¥
Jiaxing Maerte Equity Investment Pp LP
5.213 %
4,378,947 5.213 % 12 M ¥
Hangzhou Chenghe Shanda Investment Pp LP
4.153 %
3,488,000 4.153 % 10 M ¥
Hainan Fujiurong Investment Pp LP
4.010 %
3,368,421 4.010 % 9 M ¥
Zhe Wang
3.810 %
3,200,000 3.810 % 9 M ¥
New China Fund Management Co., Ltd.
0.003356 %
2,819 0.003356 % 7 930 ¥
Minsheng Royal Fund Management Co., Ltd.
0.002801 %
2,353 0.002801 % 6 619 ¥
Changsheng Fund Management Co., Ltd.
0.001518 %
1,275 0.001518 % 3 586 ¥
Manulife TEDA Fund Management Co., Ltd.
0.001462 %
1,228 0.001462 % 3 454 ¥

Company contact information

Chengda Pharmaceuticals Co., Ltd.

36 Huanghe Road Huimin Street

314100, Jiaxing

+

http://www.chengdapharm.com
address ChengDa Pharmaceuticals Co., Ltd.(301201)

Sector

Healthcare
Pharmaceuticals & Medical Research
Pharmaceuticals
Pharmaceuticals
Other Pharmaceuticals

Sales per Business

Sales per region

Sector Other Pharmaceuticals

1st Jan change Capi.
CHENGDA PHARMACEUTICALS CO., LTD. Stock ChengDa Pharmaceuticals Co., Ltd.
-20.53% 432M
ELI LILLY AND COMPANY Stock Eli Lilly and Company
+26.08% 662B
NOVO NORDISK A/S Stock Novo Nordisk A/S
+21.85% 546B
JOHNSON & JOHNSON Stock Johnson & Johnson
-4.77% 359B
MERCK & CO., INC. Stock Merck & Co., Inc.
+16.97% 323B
ABBVIE INC. Stock AbbVie Inc.
+5.69% 290B
ASTRAZENECA PLC Stock AstraZeneca PLC
+13.68% 234B
NOVARTIS AG Stock Novartis AG
+3.65% 198B
ROCHE HOLDING AG Stock Roche Holding AG
-11.12% 194B
AMGEN INC. Stock Amgen Inc.
+8.08% 167B
Other Pharmaceuticals
  1. Stock Market
  2. Equities
  3. 301201 Stock
  4. Company ChengDa Pharmaceuticals Co., Ltd.